Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Bullboard Posts
Comment by Micr1on May 16, 2010 3:01pm
559 Views
Post# 17103732

RE: One concern...

RE: One concern...Fattum, I totally agree.  But I have to admit I have a hell of a time taking the perspective in this play and when I do take a proper detached (emotionnaly speaking) perspective, I look at my DD, at all the fact lying before me and.... BAHM!  Here I go again, dreaming on the edge of my seat, refreshing my screen each 15 minutes! lol!!

GLTA

fingers crossed, Micr1
Bullboard Posts